2008
DOI: 10.3748/wjg.14.4880
|View full text |Cite
|
Sign up to set email alerts
|

Prognostic significance of BMP and activin membranebound inhibitor in colorectal cancer

Abstract: AIM:To investigate the clinical significance of BMP and activin membrane-bound inhibitor (BAMBI) which is a pseudoreceptor of transforming growth factorbeta (TGF-β) type Ⅰ receptors and acts as a negative regulator of TGF-β signaling and expression aberrantly elevated in colorectal cancers (CRCs). We studied BAMBI expression in CRCs. METHODS:We studied BAMBI expression in 183 surgically resected CRCs by immunochemical and immunoblotting analyses using a generated monoclonal anti-BAMBI antibody. Commercially av… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
24
0

Year Published

2009
2009
2016
2016

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 31 publications
(24 citation statements)
references
References 39 publications
0
24
0
Order By: Relevance
“…Currently, the role of negative regulator BAMBI in various cancers is controversially discussed. Increased BAMBI expression has been reported for colorectal cancer tissues (11,13) and ovarian cancer cells (12). In contrast, BAMBI was observed to be epigenetically silenced in high-grade bladder cancer (14) and absent in metastasizing melanoma cells (37) and breast cancer tissues (15).…”
Section: Discussionmentioning
confidence: 90%
See 1 more Smart Citation
“…Currently, the role of negative regulator BAMBI in various cancers is controversially discussed. Increased BAMBI expression has been reported for colorectal cancer tissues (11,13) and ovarian cancer cells (12). In contrast, BAMBI was observed to be epigenetically silenced in high-grade bladder cancer (14) and absent in metastasizing melanoma cells (37) and breast cancer tissues (15).…”
Section: Discussionmentioning
confidence: 90%
“…The expression of BAMBI at high levels has also been detected in colorectal cancer (11) and ovarian cancer (12) and has been linked to metastasis in colorectal cancer (13). By contrast, BAMBI is epigenetically silenced in highgrade bladder cancer (14) and absent from breast cancer (15).…”
Section: Introductionmentioning
confidence: 96%
“…Continuous BAMBI expression due to activated b-catenin (through the direct binding of TCF/LEF transcription factor to BAMBI promoter region) or TGF-b/BMP signaling itself (through the evolutionary conserved BMP-responsive elements in BAMBI promoter, by the direct binding of SMAD3 and SMAD4 to its promoter region) favors the growth and survival of colorectal cancer cells by acting as a negative feedback system against TGF-b/BMP signaling. 18,19,22,55 It follows, therefore, that colorectal cancer cells expressing the BAMBI gene with hypomethylation of the BAMBI gene promoter have a better chance of surviving in the tumor microenvironment. To the contrary, the effect of the TGF-b/BMP signaling pathway at later progression stages in some aggressive tumors, such as in malignant melanoma, 56 ovarian 57 and bladder cancers, 58,59 often promotes cancer cell invasion and migration by inducing EMT in an autocrine and paracrine manner.…”
Section: 22mentioning
confidence: 99%
“…18,[22][23][24] Members of the TGFb superfamily play an important role in cardiac development and angiogenesis, which is highlighted by the phenotypes exhibited by knockout mice. Tgfb1 knockout mice all have cardiac defects and have an embryonic lethal phenotype.…”
Section: Introductionmentioning
confidence: 99%